期刊
CURRENT ONCOLOGY REPORTS
卷 24, 期 11, 页码 1373-1375出版社
SPRINGER
DOI: 10.1007/s11912-022-01314-z
关键词
-
类别
Multimodal treatment courses for locally advanced rectal cancer can lead to significant morbidity. Nonoperative management is feasible for patients who show clinical complete response to neoadjuvant therapies. Recent reports have shown promising results for immunotherapy with checkpoint inhibition in patients with mismatch repair-deficient rectal and colon cancers.
Treatment of locally advanced rectal cancer with multimodal treatment courses can result in significant morbidity. Nonoperative management is feasible for patients with clinical complete response to neoadjuvant therapies. Several recent reports have evaluated the use of immunotherapy with checkpoint inhibition for patients with mismatch repair-deficient rectal and colon cancers, with striking results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据